Keywords: fda, clears, antisoma, ph, ii, cancer, trial

FDA clears Antisoma's Ph II cancer trial

Article | 25 April 2005

The US Food and Drug Administration has approved an Investigational New Drug application for a Phase II study of UK ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in